Pablo Corral MD

@drpablocorral

Internal Medicine Doctor. School of Medicine Professor. Lipidologist. Lipoprotein disorders. Atherosclerosis Prevention. Runner by my self and for my mind

-38.015717,-57.537636
Vrijeme pridruživanja: rujan 2009.

Tweetovi

Blokirali ste korisnika/cu @drpablocorral

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @drpablocorral

  1. proslijedio/la je Tweet
    prije 16 sati
    Poništi
  2. Poništi
  3. proslijedio/la je Tweet
    prije 20 sati
    Poništi
  4. 4. velj
    Poništi
  5. 29. sij

    Last day in CDMX 🇲🇽. Many thanks to for the invitation; great whole-day work! Thank you Octavio for your fantastic coordination. Hope to see you soon! – mjesto: Crowne Plaza

    Poništi
  6. 29. sij

    Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases

    Poništi
  7. 27. sij
    Poništi
  8. 25. sij

    A piece of art, a must read article 👏👏👏 Written by a Dream Team in FH. Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

    , , i još njih 3
    Poništi
  9. 24. sij

    I’m in!!! 👏👏👏 Hope to see lot of friends and enjoy the Science as always at

    Poništi
  10. 23. sij
    Poništi
  11. 22. sij

    The Future is Now! In Vivo AAV-CRISPR/Cas9–Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia

    , , i još njih 2
    Poništi
  12. 21. sij
    Poništi
  13. 20. sij

    ¿Son aplicables las nuevas Guías de Lípidos ESC/EAS a nuestros pacientes? Are the new lipid guides of the ESC/EAS applicable to our patients?

    Poništi
  14. proslijedio/la je Tweet
    17. sij
    Poništi
  15. 17. sij

    SAC | Sociedad Argentina de Cardiología Llamamiento mundial por la Hipercolesterolemia Familiar - SAC | Sociedad Argentina de Cardiología ⁦⁩ ⁦⁩ ⁦⁩ doi:10.1001/jamacardio.2019.5173

    Poništi
  16. 17. sij

    Potential of Lipoprotein(a)‐Lowering Strategies in Treating Coronary Artery Disease

    Poništi
  17. proslijedio/la je Tweet
    14. sij
    Poništi
  18. 14. sij

    Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    , , i još njih 4
    Poništi
  19. 11. sij

    “Love is the child of illusion and the parent of disillusion.” The Illusions of Love. in SA Special Editions 22, 3s, 72-77 (September 2013) doi:10.1038/scientificamericanillusions0913-72

    Poništi
  20. 8. sij

    Xanthomas in FH patient. 43 yo, TC 435 mg/dL, LDLc 333 mg/dL. Father MI at 44 yo. LDLR mutation (Lebanese). Rosuva 40 + Eze 10 = LDLc 139 mg/dL. Carotid bilateral plaques (50%); minor anterior ischemia in stress test. PCSK9i denied 🤦🏻‍♂️🤷🏻‍♂️

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·